DCC's £5.7 billion takeover bid has hit a significant hurdle, with founder Jim Flavin leading a chorus of prominent shareholders opposing the deal on grounds that it undervalues the company by at least £1.4 billion. This opposition comes as the board had recommended acceptance of the private equity offer, citing a premium of 11% over DCC's pre-bid share price.
With DCC's market capitalisation standing at approximately £7.1 billion, the proposed takeover would result in a significant change of control for the company, which specialises in energy and healthcare services. The founder's objections are notable given his long-standing involvement with the business, having established it in 1987.
The private equity consortium's valuation of DCC at £5.7 billion is based on an enterprise value-to-EBITDA multiple of around 8.3 times, which some analysts argue is below the market average for similar companies. While this may reflect concerns about DCC's slower-than-expected revenue growth in recent quarters, a sale at this price could potentially deprive existing investors of £1.4 billion or more.
The fallout from this takeover attempt could have significant implications for the UK's listed market, particularly if it sets a precedent for private equity firms to take advantage of undervalued companies. As one major shareholder observed, 'the DCC board needs to explain why they think this is a good deal for shareholders'.
This high-stakes battle between the founder and the board serves as a reminder that the true value of a company cannot be reduced solely to its share price or market valuation. Rather, it involves complex considerations around future growth prospects, strategic direction, and long-term shareholder value.